Group items tagged

Paul Rees MBE has joined the National Pharmacy Association (NPA) today (27 November) as its new Chief Executive. Current NPA Chief Executive Mark Lyonette, who is retiring, will remain at the NPA for some weeks in order to ensure a smooth handover. Previously, Paul has worked as the Chief Executive of the Royal College of Psychiatrists for the seven years. On joining NPA, Paul said: "It is a great privilege and honour to take up the position of NPA Chief Executive. The association is the voice of independent community pharmacy and is core to the sector's future success in England, Scotland, Wales and Northern Ireland. "I am delighted that the NPA has placed its trust in me and I intend to deliver for NPA members, for the sector and for society at large, which relies on there being a vibrant community pharmacy network in villages, towns and cities across the four nations of the UK." When Paul's appointment was first announced in September, NPA Chair Nick Kaye said that they identified him as an "excellent fit for our organisation" after a rigorous recruitment process, and also thanked Mark for his "great work as chief exec since 2018."

National Pharmacy Association (NPA) has appointed Nick Kaye as its new chair on Monday (24 April). He has taken over the chairmanship from Andrew Lane, who stood down last month after serving his maximum term. Nick, who part-owns Hendra Pharmacy in Cornwall will serve for two years as NPA chair, after being elected unopposed at the first meeting of the new NPA board. Jay Badenhorst, Managing Director and Superintendent Pharmacist for Whitworth Chemists in the North East of England, is now vice-chair. Michael Guerin, the Managing Director and Superintendent Pharmacist of the Medicare group in Northern Ireland, continues as Treasurer. Nick Kaye said: "As a third generation community pharmacist, I feel very privileged to serve the sector that I love so dearly in this way. "Andrew will be a hard act to follow. But I can promise my unwavering commitment to independent community pharmacy, with Jay and Michael's 's support, plus that of board colleagues and our dedicated executive team.

The National Pharmacy Association (NPA) has appointed Paul Rees MBE as its new Chief Executive, with his role commencing on November 27th. Rees, currently serving as the Chief Executive of the Royal College of Psychiatrists and having held various roles throughout his career, will succeed Mark Lyonette, who is retiring, NPA said in a statement. "We anticipate Paul joining the NPA after a thorough recruitment process affirmed his suitability," said Nick Kaye, Chair of NPA. "Throughout his career, including his role at the Royal College of Psychiatrists, he has made a significant impact and achieved concrete changes in healthcare and society. I would also like to express my appreciation to Mark for his work as Chief Executive since 2018. He still has important tasks to complete at the NPA before his retirement." Rees has also held key positions at prominent organisations, including the Ramblers Association, National Housing Federation, Charities Aid Foundation, Association of University Teachers, and the , besides being the Head of Communications at the Home Office.

Nick Kaye, chair of the National Pharmacy Association (NPA), gave evidence to the UK's official COVID-19 Inquiry on Monday (4 November), highlighting the importance of building a "sustainable and resilient community pharmacy network" to enhance preparedness for future pandemics. Kaye also recommended utilising the existing community pharmacy infrastructure for public health initiatives, such as vaccination programmes, and stressed the need to recognise community pharmacists and their teams as integral members of primary care. "Seven pharmacies a week are closing across the four nations, and that is tragic for any future response. So, a resilient community pharmacy network that exists is going to be key," he told the Inquiry. He noted that 90 per cent of most NPA members' income comes from providing NHS services, underscoring the critical role pharmacies play in healthcare delivery. However, Kaye highlighted that pharmacies were often overlooked and underappreciated during the pandemic.

The Pharmacists' Defence Association (PDA) has written to the National Pharmacy Association (NPA) to highlight several important points regarding their proposed "day of action" on 20 June 2024. The NPA describes this initiative as a response to the "emergency across the community pharmacy sector." In a letter addressed to NPA Chair Nick Kaye and Chief Executive Paul Rees, the PDA's director of pharmacy, Jay Badenhorst stressed the need for NPA members to consider their obligations to staff and patients before participating in the planned actions. He stated, "We are supportive of a new contractual framework for the community pharmacy sector." "However, any actions taken must ensure the safety of patients and the operational integrity of pharmacies." The PDA's letter also expressed concerns over the safety and operational impact of the proposed symbolic gestures, including turning off lights and blacking out windows.

Paul Rees MBE, chief executive of the National Pharmacy Association (NPA), has announced his resignation to take on a new role as interim chief executive and registrar of the Nursing and Midwifery Council (NMC) in the new year. He will join the NMC on a one-year contract starting January 20, where he will oversee the development of a multi-year programme aimed at transforming the NMC's culture and performance. This follows an independent culture review conducted by Nazir Afzal OBE, which highlighted issues of racism, discrimination, and bullying within the organisation. The NPA is engaging a leading recruitment agency to find its next chief executive, with plans to make an appointment early in the New Year. NPA chair Nick Kaye praised Paul's contributions over the last year, stating: "I'm enormously grateful to Paul and the brilliant NPA team who are doing so much to raise the profile of community pharmacy, campaign for a better deal and improve our outstanding support to members. "Our board and senior team are pressing ahead with our very successful campaigning and our work to transform the support and services we give to pharmacies across the country.

The National Pharmacy Association (NPA) has called on the NHS and the Department of Health to immediately publish the government-commissioned analysis of pharmacy underfunding and reveal the true scale of the crisis. Commissioned by NHS England, the long-awaited independent review is expected to "lay bare the perilous financial state" of community pharmacies, which is a vital part of the nation's health infrastructure. However, the NPA is concerned that the government may delay its release until after current funding consultations are concluded. The NPA argued that the public needs to understand the fragile nature of the pharmacy network before any new deal can be agreed. It has also warned health officials not to hide "the true scale of funding needed to reverse a decade of swingeing cuts", which has forced record numbers of pharmacy closures. NPA chair Nick Kaye said: "It would be a scandal to keep that evidence buried secret and leave MPs, pharmacies and the public in the dark." He acknowledged that the new government has inherited a crisis in pharmacy funding and emphasised that it will need to take "strong action" to maintain access to medicines.

Two weeks prior to the closing of the hub and spoke consultation, issues around patient safety, costs and competition as well as practicalities such as what to do with uncollected medicines were discussed in a webinar on hub and spoke dispensing on Wednesday (May 26). The webinar was organised by Sigma Pharmaceuticals in association with the National Pharmacy Association (NPA). NPA director of corporate affairs Gareth Jones chaired the event and was joined by Sigma's Hatul Shah and Raj Haria as well as NPA vice chair Nick Kaye and NPA head of advice and support services Jasmine Shah. Kaye said: "There are still many 'unknown unknowns' with hub and spoke and the jury's still out on any potential benefits. I have lots of reservations about cost and it worries me how efficient this is for the business and the long term sustainability for the sector as a whole. Above all we need to think about the patient at the centre of all this and the potential confusion for them." Jasmine Shah felt patient safety was going to be the key in regards to whether the spoke and the hub would hold the ultimate responsibility and "who is going to take the accountability as far as patient care goes". She added: "It is most important that GPhC standards and NHS requirement are both met in identifying all the risks associated with the arrangement with hub and spoke and ensuring that (patient safety) measures are in place. Everything that needs to be looked at is by putting the patient at heart of the arrangement and seeing what is the safest way for them to receive care from both spoke and hub."

The National Pharmacy Association (NPA) has lashed out at the British Medical Association (BMA) after GP leaders voted in favour of the motion to terminate pharmacy blood pressure checks with immediate effect and redirect the funds into pharmacy dispensing fees. Commenting on the BMA's vote, NPA chair Nick Kaye said: "It benefits no-one, least of all patients, for one set of health care professionals to talk down the services provided by another." He emphasised the importance of investment and collaboration across the healthcare system, particularly between general practice and community pharmacies, to provide the best possible care for patients. Furthermore, Kaye stressed the value of pharmacy-based NHS clinical services in improving access to care, while also providing more convenient care for patients and relieving pressure on other parts of primary care. "It would be terribly shortsighted to row back on preventative services such as hypertension case finding, which will be cost-saving as well as lifesaving in the long term," he warned. He noted that the NHS will only meet the growing needs and expectations of the ageing population by making the most of capacity and skills across the whole system.

Pharmacy teams across the country are joining forces for the second day of protest, organised by the National Pharmacy Association (NPA), as part of its #SaveOurPharmacies campaign, on Thursday (September 19). A cross-sector delegation will present a petition signed by a record-breaking 350,000 people to No 10 Downing Street. The delegation will include National Pharmacy Association (NPA) CEO Paul Rees, NPA Chair Nick Kaye, Community Pharmacy England (CPE) Chief Executive Janet Morrison, Company Chemists' Association (CCA) CEO Malcolm Harrison, and Community Pharmacy NI Chief Executive Gerard Greene, The Save Our Pharmacies petition has surpassed the previous record held by a Royal College of GPs in 2014, whose petition, addressing the issue of general practice funding, secured 300,000 signatures. The NPA is hopeful that this show of solidarity by pharmacy teams will make a difference and open up conversations in Westminster and Whitehall.

The National Pharmacy Association (NPA) has disclosed alarming figures on pharmacy closure in England, attributing them to the impact of funding cuts. According to NPA analysis of NHS Business Services Authority (NHSBSA) data, 222 pharmacies permanently closed their doors in 2024, marking the second-highest annual closure rate on record. This equates to an average of four pharmacies closing each week. Nearly 90 per cent of council areas have seen at least one pharmacy shut permanently in just the last two years. NPA chair Nick Kaye voiced concern that pharmacies have been "pushed to breaking point" by 40 per cent real terms cuts to their budgets and the ones still open are left "hanging on by their fingertips" and could be forced to close without "an urgent increase in their funding." "It is patients that have lost out the most, with more people in isolated areas having to travel further for vital medication as well as access to medical advice convenient to them," he said.

'Community pharmacy is far too important to be allowed to wither away' desc-Thousands of pharmacies took part in the second day of the 'Save Our Pharmacies' protest organised by the National Pharmacy Association (NPA) on Thursday. Similar to the first day of protest in June, pharmacies carried out several symbolic actions, such as blacking out windows, to warn of the threat of future closures. Meanwhile, NPA chief executive Paul Rees led a delegation of pharmacy leaders to deliver a 350,000-strong petition to No 10 Downing Street, calling for "immediate, fair and sustained funding to safeguard NHS pharmacy services and ensure local pharmacies have a future." The delegation included NPA Chair Nick Kaye; Janet Morrison, CEO of Community Pharmacy England (CPE); Malcolm Harrison, CEO of Company Chemists' Association (CCA), and Gerard Greene, CEO of Community Pharmacy Northern Ireland (CPNI). Steve Race MP, who is the new chair of the All-Party Parliamentary Group on Pharmacy, and Sadik Al-Hassan, one of only two pharmacists in the House of Commons, also joined them.

At the Covid Inquiry on Tuesday, Sir Chris Wormald, permanent secretary at the Department of Health and Social Care (DHSC), was questioned about the initial exclusion of community pharmacies in the government's emergency pandemic life assurance scheme. Earlier this month, the National Pharmacy Association (NPA) submitted evidence to the inquiry highlighting the delay in including community pharmacies in the scheme - which offered £60,000 lump sum payments to NHS and care home staff who died from Covid. The inquiry heard that the scheme was launched on April 27, 2020, initially covering NHS and care home staff. However, then Health Secretary Matt Hancock only confirmed the inclusion of community pharmacy staff in a Tweet three days later, on April 30. NPA Chair Nick Kaye told the inquiry that it was "demoralising and demotivating" to community pharmacy staff who worked throughout the pandemic. Jacqueline Carey KC, Counsel to the Covid Inquiry, put the charge to Sir Wormald as he gave evidence about the department's response to the pandemic.

Ensuring comprehensive healthcare services for the community necessitates collaboration between pharmacies and GP surgeries. However, several pharmacists have voiced concerns about a lack of cooperation from their local GPs in implementing the Pharmacy First (PF) service. In a survey conducted by the National Pharmacy Association (NPA) covering 470 pharmacies across England, three-quarters of pharmacists (77 per cent) indicated that local GP practices are not appropriately referring patients to the new service. The survey highlighted instances of patients either not being referred or being referred but found ineligible for support through Pharmacy First. Additionally, one in five NPA members (19 per cent) felt that their local GP practices were not engaging with the initiative at all. Commenting on the issue, NPA chair Nick Kaye said: "Feedback from across our network suggests that the rollout of Pharmacy First varies considerably from area to area.

The National Pharmacy Association has published a medium-term prospectus for the development of pharmacy services, calling it a challenge to old ways of thinking and an opportunity to redefine the sector's role in the NHS. It follows months of dialogue with NPA members about what a clinical future could look like for the sector. The document - Making Changes Meeting Needs - will be shared with the King's Fund and Nuffield Trust who are currently working on a new vision for the future on behalf of Community Pharmacy England. NPA chair, Nick Kaye, said: "Building out from the existing portfolio of services, there are some major opportunities within this decade, encompassing prevention, medicines optimisation, long term medical conditions and urgent care.

Community pharmacy bodies have said that the current crippling financial pressures and severe staff shortages will limit the sector from fully supporting the new health secretary's ambition to improve patient care in England. Thérèse Coffey announced her plans on Thursday (September 22) which would be looking to reduce the country's reliance on general practice by expanding the range of services available from community pharmacies and allowing pharmacists more "prescribing powers". "Pharmacists will be able to manage and supply more medicines, without a prescription from a GP. We will look to go further on enabling pharmacists with more prescribing powers and making more simple diagnostic tests available in community pharmacy," she said in her foreword to Our Plan for Patients. However, the National Pharmacy Association has lamented that the plan stops short of promising any fresh funding for community pharmacies to deliver patient care and develop clinical services. NPA vice-chair, Nick Kaye, said: "The life is being choked out of independent pharmacy businesses by the continuation of a fundamentally under-resourced contract in England.